总部位于圣地亚哥的DNA测序和基因芯片技术全球领导者Illumina(NASDAQ:ILMN)今日宣布,预计2025财年非公认会计准则(non-GAAP)每股摊薄收益(EPS)约为4.50美元。该指引与InvestingPro分析师预测的每股4.59美元基本一致,显示公司有望从当前过去十二个月每股-7.69美元的亏损中实现显著转折。此财务展望是对近期中国商务部(MOFCOM)禁止Illumina测 ...
这位靠资产收购、整合几度成为地球首富的法国人是一位“天才”交易者。作为LVMH(路威酩轩)集团全球总部家族办公室资产管理人,以及该机构当时全球唯一的亚裔成员,赵博文的投资理念亦受其影响。之后赵博文又加入A ...
在美国总统唐纳德·特朗普(Donald ...
即便在华市场受到重创,因美纳的行业领先地位仍然不容忽视,禁令后续的影响目前来看还有待进一步观察,不过可以确定的是,基因测序仪领域的国产替代进程势必进一步加速,利好国内相关企业。 3月4日,中国商务部宣布,禁止美国生物科技公司因美纳公司向中国出口基因测序仪。此前的2月4日,中国商务部宣布,将因美纳列入“不可靠实体清单”。
March 10 (Reuters) - Illumina (ILMN.O), opens new tab on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ...
(RTTNews) - Illumina, Inc. (ILMN) responded on Monday to the notice from the China Ministry of Commerce stating that it is not permitted to export sequencing instruments into China. Illumina said ...
Illumina is reducing its forecast for this year’s financial performance and cutting $100 million in spending because China barred sales of the company’s gene-sequencing machines. San Diego ...
In a case that had been closely watched across multiple industries, Illumina chose to divest Grail in the light of legal action from the European Commission and the US Federal Trade Commission.
标的公司目前拥有一台向Illumina采购的高通量测序设备和两台华大智造投放使用的高通量测序设备。 据悉,组学行业产业链上游主要为设备研发 ...
净值估算数据按照基金历史披露持仓和指数走势估算,不构成投资建议,仅供参考,实际以基金公司披露净值为准。 净值估算是按照基金历史定期报告公布的持仓和指数走势预测当天净值。预估 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results